Select Page
Skip to main content
Categories
< All Topics
Print

eCTD

The electronic Common Technical Document (eCTD) is the standardised electronic format used to organise, submit and manage regulatory information for pharmaceutical products. It is based on the Common Technical Document (CTD) structure developed through the International Council for Harmonisation (ICH).

Unlike a simple collection of electronic documents, eCTD provides a structured technical framework that enables regulatory submissions to be managed throughout the lifecycle of a medicinal product.

For the underlying CTD content structure, see Common Technical Document and eCTD.

Five-Module Submission Structure

The electronic submission follows the five-module CTD structure:

Module 1 – Regional Administrative and Prescribing Information

Contains information specific to the regulatory region receiving the submission.

Module 2 – CTD Summaries

Contains quality, nonclinical and clinical summaries and overviews.

Module 3 – Quality

Contains detailed quality and manufacturing information for the drug substance and drug product.

Module 4 – Nonclinical Study Reports

Contains detailed reports from pharmacology, pharmacokinetic and toxicology studies.

Module 5 – Clinical Study Reports

Contains clinical study reports and supporting clinical information.

Sequences and Lifecycle Management

An important feature of the electronic submission framework is lifecycle management. Regulatory information is submitted through sequences that collectively form the regulatory history of an application.

After an initial submission, subsequent sequences can provide additional information or manage documents as the application progresses. This enables regulatory authorities and applicants to maintain an organised view of the submission throughout the product lifecycle.

Benefits of Electronic Regulatory Submissions

This structured approach provides several advantages for applicants and regulatory authorities:

  • Standardised organisation of regulatory information
  • Efficient navigation and review of submission documents
  • Electronic transmission of regulatory applications
  • Lifecycle management of documents and submissions
  • Improved consistency across regulatory submissions
  • Reduced dependence on paper-based submission processes

eCTD v3.2.2 and eCTD v4.0

eCTD v3.2.2 has been widely used internationally and continues to remain relevant in regulatory regions and submission contexts where it is supported.

eCTD v4.0 is the next major version of the electronic submission standard. It introduces an updated technical architecture and enhanced capabilities for managing regulatory information and communication.

Implementation of eCTD v4.0 is occurring at different times across regulatory regions. Applicants must therefore determine which eCTD version and regional requirements are currently accepted or required by the regulatory authority receiving the submission.

Regional Implementation Requirements

Although the standard uses an internationally harmonised technical framework, regional requirements remain important.

Regulatory authorities publish their own Module 1 specifications, validation criteria, controlled vocabularies, technical requirements and submission procedures. Applicants must therefore follow both the applicable ICH standard and the current regional implementation guidance.

Current Transition to eCTD v4.0

The global regulatory environment is currently transitioning toward eCTD v4.0, but implementation is not simultaneous worldwide.

Some regulatory authorities already accept or require eCTD v4.0, while others continue to support eCTD v3.2.2 or are implementing v4.0 through phased transition programmes.

For this reason, applicants should always verify the current requirements of the relevant regulatory authority before preparing or submitting an eCTD application.

This electronic submission framework combines the harmonised CTD content structure with lifecycle management capabilities, supporting efficient exchange and review of regulatory information throughout the medicinal product lifecycle.

Current specifications and regional implementation information are available through the ICH eCTD v4.0 resources.

You may be interested in the programs below: